| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-müllerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy
|
Fréour, T.
|
|
2017
|
74 |
C |
p. 1-8
8 p.
|
artikel
|
| 2 |
Cervical cancer incidence in elderly women-biology or screening history?
|
Lynge, Elsebeth
|
|
2017
|
74 |
C |
p. 82-88
7 p.
|
artikel
|
| 3 |
Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients
|
Longhi, A.
|
|
2017
|
74 |
C |
p. 9-16
8 p.
|
artikel
|
| 4 |
Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients
|
Aparicio, Thomas
|
|
2017
|
74 |
C |
p. 98-108
11 p.
|
artikel
|
| 5 |
Geriatric factors and outcomes in metastatic colorectal cancer
|
Papamichael, Demetris
|
|
2017
|
74 |
C |
p. 96-97
2 p.
|
artikel
|
| 6 |
Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study
|
Schroeder, Lea
|
|
2017
|
74 |
C |
p. 73-81
9 p.
|
artikel
|
| 7 |
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
|
Mukherjee, Somnath
|
|
2017
|
74 |
C |
p. 38-46
9 p.
|
artikel
|
| 8 |
Policy and priorities for national cancer control planning in low- and middle-income countries: Lessons from the Association of Southeast Asian Nations (ASEAN) Costs in Oncology prospective cohort study
|
|
|
2017
|
74 |
C |
p. 26-37
12 p.
|
artikel
|
| 9 |
Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis
|
Leone, José Pablo
|
|
2017
|
74 |
C |
p. 17-25
9 p.
|
artikel
|
| 10 |
Second- and third-generation drugs for immuno-oncology treatment—The more the better?
|
Dempke, Wolfram C.M.
|
|
2017
|
74 |
C |
p. 55-72
18 p.
|
artikel
|
| 11 |
The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials
|
Donia, Marco
|
|
2017
|
74 |
C |
p. 89-95
7 p.
|
artikel
|
| 12 |
Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study
|
van Ramshorst, Mette S.
|
|
2017
|
74 |
C |
p. 47-54
8 p.
|
artikel
|
Tijdschrift beschrijving